The Netherlands Neurology Clinical Trials market is projected to grow from $13.6 Mn in 2022 to $21.7 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022 - 2030. The market will be driven by the modern healthcare infrastructure and an innovative & collaborative research environment. The market is segmented by phase, by study design & by indication. Some of the major players include Biogen Netherlands BV, Roche Holding AG & Johnson & Johnson.
The Netherlands Neurology Clinical Trials market is projected to grow from $13.6 Mn in 2022 to $21.7 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022 - 2030. Alzheimer's and dementia fatalities in the Netherlands reached 18,148 in 2020, accounting for 14.31% of total deaths, based on the most recent WHO statistics. The Netherlands ranks seventh in the world with an age-adjusted death rate of 33.78 per 100,000 inhabitants. There are around 120,000 individuals in the Netherlands who have active epilepsy.
The Netherlands has a reasonably robust neurology clinical trials market owing to the country's well-established healthcare system, research infrastructure, and supportive regulatory environment. The Netherlands has a long history of excelling in medical research, notably in the area of neuroscience, and it is home to a number of world-class university medical institutes such as Amsterdam University Medical Centers, Radboud University Medical Center & University Medical Center Groningen that perform clinical trials in the subject. Moreover, companies such as Biogen, UCB, Janssen & AbbVie have also been keen on performing clinical trials in the Netherlands.
The nation also has a well-developed clinical research regulatory system, including the Central Council on Research Involving Human Subjects (CCMO), which monitors clinical trials involving human volunteers. The CCMO guarantees that clinical trials in the Netherlands are ethical, transparent, and in accordance with national and international legislation.
Market Growth Drivers
The Netherlands has been an active participant in neurology clinical trials. The modern healthcare infrastructure, along with an innovative research environment, is one of the major drivers of the country's rise in neurology clinical trials. The country's healthcare system is well-known for providing high-quality treatment and efficient administration. The nation also has a well-developed clinical research regulatory structure, including the Central Council on Research Involving Human Subjects (CCMO), which regulates clinical trials with human subjects.
Moreover, the Netherlands has an extensive network of academic universities and research organisations dedicated to neurological research. This network facilitates cooperation among researchers, physicians, and industry partners, creating an environment favourable to the development of innovative treatments and therapies for neurological illnesses.
there are a number of constraints that might limit the expansion of neurology clinical trials in the Netherlands. The rising complexity and expense of clinical trials are one of the most critical issues. Clinical trials for neurological illnesses sometimes need a large number of patients and sophisticated research designs, making them costly to undertake. This may restrict the number of studies that may be carried out in the Netherlands, particularly for smaller enterprises or academic institutions with little finance. Another difficulty is growing competition from other nations, notably those in Eastern Europe and Asia, which are drawing more clinical trials due to cheaper prices and less severe regulations. Competitiveness may result in fewer clinical trials being done in the Netherlands, limiting the country's ability to contribute to the discovery of innovative therapies for neurological illnesses.
January 2023, The FDA approved Eisai, a Biogen Alzheimer's drug.
The Netherlands has completely adopted the EU Clinical Trials Directive (CTD). An identical Clinical Trial Application (CTA) document must be submitted in tandem with an authorised Ethics Committee and the Centrale Commissie Mensgebonden Onderzoek (CCMO=Competent Authority) prior to the start of a clinical study. The research may begin after the Ethics Committee has given its approval and the Competent Authority has issued a declaration of no objection.
1. Report Description of the Netherlands Neurology Clinical Trials Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Netherlands Neurology Clinical Trials Market Executive Summary
2.1 Netherlands Neurology Clinical Trials Market –Industry Snapshot & key buying criteria, 2022-2030
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of the Netherlands Neurology Clinical Trials Market
3.1 Market Growth Drivers Analysis
3.2 Market Restrains Analysis
4. Netherlands Neurology Clinical Trials Market Segmentation
4.1 By Phase
4.1.1 Phase I
4.1.2 Phase II
4.1.3 Phase III
4.1.4 Phase IV
4.2 By Study Design Outlook
4.2.2 Parkinson's Disease (PD)
4.2.3 Huntington's Disease
4.2.5 Traumatic Brain Injury (TBI)
4.2.6 Amyotrophic Lateral Sclerosis (ALS)
4.2.7 Muscle regeneration
4.3 By Indication Outlook
4.3.3 Expanded Access
5. Netherlands Neurology Clinical Trials Market Share
5.1 Market Analysis, Insights, and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
7. Key Company Profiles
7.1 Company 1
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives
7.2 Company 2
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives
7.3 Company 3
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives
7.4 Company 4
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives
7.5 Company 5
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives
8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in Netherlands
8.2 Regulatory Framework in Netherlands
8.3 Pricing & Reimbursement Scenario in Netherlands Neurology Clinical Trials Market
9. Factors Driving Future Growth
9.1 New Trends and Development Netherlands Neurology Clinical Trials Market
9.2 Future Opportunities
10. Strategic Recommendations
By Phase (Revenue, USD Billion):
By Study Design Outlook (Revenue, USD Billion):
By Indication Outlook (Revenue, USD Billion):
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses